Exosomal CircRNAs in Circulation Serve as Diagnostic Biomarkers for Acute Myocardial Infarction

Xiaoyan Liu1,2,3, Yeping Zhang1,2, Wen Yuan3

  • 1Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chao-Yang Hospital, Capital Medical University, 100020 Beijing, China.

Insights

Circular RNAs (circRNAs) in exosomes show altered expression in acute myocardial infarction (AMI) patients. The circRNA hsa_circ_0001558 is a promising biomarker for diagnosing AMI, differentiating it from non-cardiogenic chest pain.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiovascular Research

Background:

  • The diagnostic utility of exosomal circular RNAs (circRNAs) for acute myocardial infarction (AMI) remains underexplored.
  • Existing research suggests a role for circRNAs in cardiovascular diseases.

Purpose of the Study:

  • To investigate the diagnostic potential of exosomal circRNAs as biomarkers for AMI.
  • To identify specific circRNAs that are differentially expressed in AMI patients.

Main Methods:

  • High-throughput sequencing was used to identify differentially expressed circRNAs in exosomes from AMI patients.
  • Real-Time polymerase chain reaction (RT-PCR) was employed to validate the expression of selected circRNAs.
  • The study included 120 AMI patients and 83 patients with non-cardiogenic chest pain (NCCP).

Main Results:

  • Sequencing revealed 893 differentially expressed exosomal circRNAs in AMI patients (118 up-regulated, 775 down-regulated).
  • Three circRNAs (hsa_circ_0001558, hsa_circ_0001535, hsa_circ_0000972) were significantly up-regulated in AMI patients, with AUC values ranging from 0.683 to 0.79.
  • hsa_circ_0001558 showed a 4.45-fold increase in AMI patients (AUC = 0.793), with higher expression in ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI) compared to NCCP.

Conclusions:

  • Significant differences in exosomal circRNA expression exist between AMI and NCCP patients.
  • hsa_circ_0001558 is identified as a potential diagnostic biomarker for AMI.
  • Further research is warranted to fully establish the clinical utility of exosomal circRNAs for AMI diagnosis.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
144
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
81
Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K